Frank Borriello
Aviad Pato
Karrie Wong
Vicki Plaks
Stefanie Mandl
Samia Khan
Michael O'Dwyer
Justin Edwards
Jonathan Gilbert
Jonathan Gilbert, PhD joined SQZ in 2013 and has been a key player in the growth and development of the company from its formative stages. As the Vice President of Exploratory Research, he is applying the Cell Squeeze Technology to generate new cell therapy concepts in multiple disease areas from cancer to regenerative medicine. In previous roles he lead Business Development as well as managing active partnerships such as the >$1B Collaboration with Roche. Dr. Gilbert received his PhD in Chemical Engineering from MIT, where he was a Presidential Fellow, and studied biomedical applications of structured polyelectrolyte films with Professor Robert Cohen and Professor Michael Rubner. He has published over a dozen articles and is an inventor on 8 patents.
Geoff Hodge
Geoff is the CEO of SOTIO Biotech US, a Cambridge, MA based subsidiary of SOTIO Biotech a.s. that is focused on the development of novel cell therapies to treat solid tumor cancers. He has over 30 years of experience in the biotechnology industry, providing bioprocessing technical solutions for companies including GE Healthcare Life Sciences (Cytiva), Millennium Pharmaceuticals (Takeda), Genetics Institute (Wyeth/Pfizer) and Alpha-Beta Technology. He is an inventor on more than a dozen bioprocess equipment and technology patents.
Prior to SOTIO, Geoff was Chief Technical Officer at Unum Therapeutics, where he managed all technical operations for the company—including process and analytical development, manufacturing, and quality—for the company’s clinical phase viral vector and T-cell processes, as well as overseeing corporate IT, facilities, and logistics. He was previously a co-founder of Xcellerex, a company pioneering single-use bioreactors, mixers, facilities, and GMP manufacturing services, featuring single-use manufacturing and high-throughput process development services. He is the inventor of record on multiple core technology patents for Xcellerex, and served as an operations leader at GE Healthcare Life Sciences after GE acquired Xcellerex. Geoff holds an M.S. in Biotechnology from WPI and Bachelor’s degree in Biology from Colgate University.